Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs11190861 | chr10:102941392 | C/T | 5.45E-8 | 178 | 15.77 | 13.6 | 3.17 | KM Plot |
| PAAD | rs11190863 | chr10:102943301 | C/T | 5.83E-8 | 177 | 15.82 | 13.6 | 3.17 | KM Plot |
| PAAD | rs11190864 | chr10:102945820 | C/T | 1.27E-7 | 173 | 15.82 | 13.6 | 3.17 | KM Plot |
| PAAD | rs11190865 | chr10:102948322 | G/A | 1.56E-7 | 172 | 15.82 | 14.03 | 3.17 | KM Plot |
| PAAD | rs111941293 | chr2:70519291 | G/A | 0 | 177 | 15.37 | 17.32 | 1.03 | KM Plot |
| PAAD | rs111952587 | chr2:128508706 | G/A | 7.9E-10 | 178 | 15.62 | 12.6 | 2.2 | KM Plot |
| PAAD | rs111972498 | chr11:125579367 | A/G | 0.000112 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
| PAAD | rs111996925 | chr11:125530756 | C/T | 4.72E-5 | 178 | 16.03 | 11.6 | 4.1 | KM Plot |
| PAAD | rs111996994 | chr1:227567209 | A/G | 6.96E-5 | 176 | 15.4 | 16.45 | 3.9 | KM Plot |
| PAAD | rs112006512 | chr3:136308750 | G/T | 7.86E-5 | 175 | 15.67 | 13.47 | 4 | KM Plot |
| PAAD | rs112038839 | chr2:70525385 | T/C | 0 | 177 | 15.33 | 17.4 | 1.03 | KM Plot |
| PAAD | rs112047121 | chr1:227571113 | G/C | 6.51E-5 | 176 | 15.42 | 17.03 | 3.9 | KM Plot |
| PAAD | rs11204743 | chr1:150890406 | A/T | 6.6E-6 | 170 | 13.13 | 16.07 | 23.4 | KM Plot |
| PAAD | rs112098079 | chr11:125757234 | CA/C | 4.21E-7 | 173 | 16.13 | 12.2 | 4.43 | KM Plot |
| PAAD | rs112098825 | chr17:40302271 | A/G | 0.000153 | 177 | 15.57 | 13.8 | 4 | KM Plot |